MKPL evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-22T23:40:56.808571+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 3828752000.0
- net_income
- 68290000.0
- operating_cash_flow
- 38051000.0
- free_cash_flow
- 19099000.0
- total_assets
- 1311970000.0
- total_liabilities
- 548968000.0
- total_equity
- 763002000.0
- cash
- 4382000.0
- total_debt
- 371377000.0
- revenue_growth
- 0.42766607527856015
- earnings_growth
- -0.18677209612499102
- net_margin
- 0.017836099073536234
- roe
- 0.08950173131918396
- debt_to_equity
- 0.48673135850233684
- cash_conversion
- 0.557197247034705
- free_cash_flow_margin
- 0.004988309506596405
- trailing_pe
- Not supplied
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-f3c910f5531f2d76cc9cd0b6fb530b0fb83f10813e721af3777b7974d600302b
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 84dfaf9530b3f5c6d2f444d3462f04e283371efbc4eb858cf53025d5016a6cb2
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 9fd8e7b5f6d4c19ca5eb625a088b569b6e25dae9f703d45bc385ac59d5d02c6c
- daily-price: 4b8311299f94cb79395b39b57cf5cc2730783c97e71bf442d7947547239cdf4c
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: VERIFIED.
- The cached closing price on 2026-10-01 was INR 3.90.
- The trailing 5-session price return was -2.74%.
- The trailing 20-session price return was -2.50%.
- The trailing 60-session price return was -16.31%.
- The trailing 250-session price return was -44.44%.
- Average cached traded value over twenty sessions was INR 350,745.
- The closing price was -45.98% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-22T23:40:56.808571+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.42766607527856015.
- The cached financial metric net margin is 0.017836099073536234.
- The cached financial metric roe is 0.08950173131918396.
- The cached financial metric debt to equity is 0.48673135850233684.
- The cached financial metric cash conversion is 0.557197247034705.
- The cached financial metric free cash flow margin is 0.004988309506596405.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.